Bio Medica Laboratories Limited IPO Details
SME
Bio Medica Laboratories IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.
Bio Medica Laboratories IPO total issue size comprises 37,71,600 shares . This includes a fresh issue of 32,05,200 shares . Offer for Sale consists of 3,76,800 shares . Pre-issue shareholding stands at 91,80,001, which will increase to 1,25,74,801 post-issue.
The Lead Managers for Bio Medica Laboratories IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Narnolia Financial Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Bio Medica Laboratories Limited DRHP.
Bio Medica Laboratories IPO Details
Bio Medica Laboratories IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Bio Medica Laboratories IPO Reservation
Promoter Holding
Documents
Bio Medica Laboratories IPO Valuations
Bio Medica Laboratories Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 39.12 | 19.53 | 17.57 |
| Total Income | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 9.79 | 2.50 | 0.33 |
| EBITDA | 15.21 | 5.63 | 1.70 |
| Net Worth | 14.73 | 4.94 | 2.44 |
| Reserves and Surplus | 5.55 | 4.84 | 2.34 |
| Total Borrowing | 15.01 | 10.49 | 9.61 |
| Amount in ₹ Crore | |||
About Bio Medica Laboratories IPO
Bio Medica Laboratories specializes in the manufacturing of pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in the form of liquid iand dry powder injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Product portfolio:
- Liquid Injectables: 58 products are offered under this category
- Dry powder injectables: 15 products under this category
It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.
The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.
It has two manufacturing facilities in Indore, Madhya Pradesh.
Competitive Strengths
- Multi-product capability and diversified product portfolio
- Experienced promoters, management and employees.
- Quality assurance
- Established client relationship
Strength Of Bio Medica Laboratories IPO
Risk Of Bio Medica Laboratories IPO
Objectives Bio Medica Laboratories IPO
1. Repayment of Loan
2. Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
3. General Corporate Purposes
Company Contact Details
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
To be announced
Read more about Shringar House of Mangalsutra IPO
- Bio Medica Laboratories Limited IPO Detail
- Bio Medica Laboratories Limited IPO Subscription Detail
- Bio Medica Laboratories Limited IPO GMP Detail
- Checked Live Bio Medica Laboratories Limited IPO Allotment Status
- Bio Medica Laboratories Limited IPO Basis Of Allotment
- Bio Medica Laboratories Limited IPO Price Calculator
- Bio Medica Laboratories Limited IPO Stock Price